You searched for "Genetics"

729 results found

Getting started in research

Dave had a passion for research and was very encouraging in developing a research interest in others. Bhavisha and Amanda are currently working with a team of researchers, patients, research funders, the Department of Health and Social Care and NHS England, to develop the 2023-2028 UK Action Plan for Hearing loss and Tinnitus Research - a set of recommendations to grow hearing research in the UK. Here, they discuss their journey to hearing care research and how you could get involved in the world of research.

HEAL 2024: Hearing Across the Lifespan

This year around 350 people representing 40 countries attended, with about 290 oral and poster presentations. Special sessions addressed a range of global challenges, including Precision Diagnostics and Therapy Across the Lifespan, Empowering healthcare professionals in supporting older adults with comorbid hearing and cognitive impairment Listening effort and Ecological Momentary Assessment.

Lost voices – service induced hearing loss on working age veterans

The Royal British Legion campaign for the recognition of hearing loss in serving personnel and veterans In July 2014, the Royal British Legion launched a report entitled Lost Voices revealing that veterans under the age of 75 are three-and-a-half times...

Current update on vestibular and balance disorders in children

Vestibular and balance disorders in children with hearing loss often go unrecognised. This article describes the significant impact such disorders have on the various aspects of children’s development. Vestibular and balance disorders occur in the paediatric population but can go...

In conversation with Professor David Kemp

Ted Killan, Vice-Chair of the British Society of Audiology (BSA), caught up with Professor Kemp to discuss his scientific journey over the past 40 years, and what we can expect from OAEs in the future. Prof David T Kemp. In...

Nature or nurture in surgical training

It’s Thursday in the UK, so that means time for another root and branch reform of medical training. If you’re not keen on the Greenaway Report (Shape of Training review) [1], don’t fret there’ll be another one along well before...

CI Advocacy in Action 2025

Helen Cullington, Professor of Cochlear Implants at the University of Southampton Auditory Implant Service, UKThe second global CIICA conference took place in Brussels in October. There were delegates from 32 countries, and more than 30 participants with cochlear implants! Live...

Brussels, a multicultural city with varied ENT practice

Brussels has a proud history in the world of ENT. Jérome Lechien, who is on the Communications Committee for the CEORL-HNS 2019 Congress, and Daniele de Siati, a member of the international Scientific Committee, give us a history lesson and...

Hyposalivation: a review of current and future treatments

Hyposalivation remains a stubbornly difficult condition to treat, but novel therapies may not be far away. Saliva has many essential functions, including aiding digestion and swallowing, lubrication, maintaining tooth integrity and antibacterial activity. When patients experience reduced saliva production (hyposalivation),...

From the editor Nov/Dec 2025

Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. TW / X: @Voicedoctor_uk For ENT&A Nov/Dec2025, we are delighted to celebrate the remarkable educational institution ENT Masterclass®, which marks its 20th anniversary with...

What’s new in laryngology: the next 10 years!

At a time of unprecedented technological advances, Taran Tatla and Jonathan Fishman gaze into the laryngological crystal ball… Introduction The recent explosion in science, technology and innovation takes us into a new era, with the opportunity and capability to transform...

Biologic therapies for chronic rhinosinusitis with nasal polyps: a new paradigm

Surgery for nasal polyposis has evolved significantly in the last 30 years, and now the medical management may be on the cusp of a revolution. Biologics using monoclonal antibodies to target specific immune pathways have introduced a paradigm shift in...